Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Sports Medicine - Open|June 25, 2022
Resuming Training in High-Level Athletes After Mild COVID-19 Infection: A Multicenter Prospective Study (ASCCOVID-19)Laurent Chevalier, Hubert Cochet, Saagar Mahida, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm laborClaudine Serradeil-Le Gal, Gérard Valette, Loïc Foulon, et al.
Clinical Laboratory|September 23, 2010
Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systemsFrançoise Lunel-Fabiani, Xavier Duburcq, Thierry Levayer, et al.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2011
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Molecular Psychiatry|May 30, 2012
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weightF G Revel, J-L Moreau, B Pouzet, et al.
Nature Communications|January 17, 2023
Complementary peptides represent a credible alternative to agrochemicals by activating translation of targeted proteinsMélanie Ormancey, Bruno Guillotin, Rémy Merret, et al.
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Nature Communications|May 30, 2026
COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathyMicol Falabella, Sandra Lopez Calcerrada, Jana Aref, et al.
The Journal of Clinical Investigation|June 11, 2026
Biallelic inactivating variants in the chromatin remodeler DMAP1 cause a syndromic neurodevelopmental disorderQin Wang, Andrew K Sobering, Christian Tirrito, et al.
Pageof 19